ISSN: 1551-7411
Journal Home
Journal Guideline
Research in Social and Administrative Pharmacy Q1 Unclaimed
Research in Social and Administrative Pharmacy is a journal indexed in SJR in Pharmaceutical Science and Pharmacy with an H index of 69. It has an SJR impact factor of 0,833 and it has a best quartile of Q1. It has an SJR impact factor of 0,833.
Research in Social and Administrative Pharmacy focuses its scope in these topics and keywords: behavior, disease, headache, guided, green, friendly, expenditures, expenditure, excess, health, ...
Type: Journal
Type of Copyright:
Languages:
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,833
SJR Impact factor69
H Index167
Total Docs (Last Year)747
Total Docs (3 years)8486
Total Refs2511
Total Cites (3 years)621
Citable Docs (3 years)3.79
Cites/Doc (2 years)50.81
Ref/DocOther journals with similar parameters
Nano Today Q1
Advanced Drug Delivery Reviews Q1
Advanced healthcare materials Q1
Journal of Controlled Release Q1
Journal of Nanobiotechnology Q1
Compare this journals
Aims and Scope
Best articles by citations
Prior authorization policies in Medicaid programs: The importance of study design and analysis on findings and outcomes from research
View moreEnvironmental and individual predictors of medication adherence among elderly patients with hypertension and chronic kidney disease: A geospatial approach
View moreGeneral practice pharmacists in England: Integration, mediation and professional dynamics
View moreUse of disease modifying agents in patients with multiple sclerosis: Analysis of ten years of national data
View moreImproving over-the-counter medication safety for older adults: A study protocol for a demonstration and dissemination study
View moreThe antibiotic knowledge, attitudes and behaviors of patients, doctors and pharmacists in the WHO Eastern European region -a qualitative, comparative analysis of the culture of antibiotic use in Armenia, Georgia, Kazakhstan, Moldova, Russia and Tajik
View moreReexamining shift work pharmacists in Illinois
View moreKey stakeholders' views on the potential implementation of pharmacist prescribing: A qualitative investigation
View moreThe use of non-prescription medicines during lactation: A qualitative study of community pharmacists' attitudes and perspectives
View moreCost-related nonadherence to medicines in people with multiple chronic conditions
View moreWhy Do Family Physicians Prescribe Fall Related Medicines for Elderly? A Qualitative Study
View moreMy Medicines and Me Questionnaire (M3Q): A novel tool for the assessment of subjective experiences of side effects in mental health consumers
View moreAdvice on Weight Management: Are Pharmacy Staff Getting It Right? Results from a Mystery Shopper Study
View moreThe birth of Research in Social & Administrative Pharmacy: a sincere welcome to subscribers, readers, and authors
View moreDeveloping implementation strategies to improve uptake of guideline-recommended treatments for individuals with familial hypercholesterolemia: A protocol
View moreOB/GYN perceptions of Prescription Drug Monitoring Programs as a primary prevention tool for neonatal abstinence syndrome
View moreRoles and responsibilities of pharmacists with respect to natural health products: Key informant interviews
View moreAdvancing clinical practice through research: a practical session on how to develop a research funding application
View moreGenerosity, collegiality, and scientific accuracy when writing and reviewing original research
View moreThe effectiveness of written communication for decision support in clinical practice
View moreDo positive attitudes to pharmacists mean that pharmacies are the first port of call for minor illnesses?
View moreResults of the Arizona Medicaid Health Information Technology Pharmacy Focus Groups
View moreEncounters with immigrant customers: perspectives of Danish community pharmacy staff on challenges and solutions
View morePrevalence and correlates of self-reported medication non-adherence among older adults with coronary heart disease, diabetes mellitus, and/or hypertension
View more
Comments